These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 33107199)

  • 1. 5-Hydroxymethylcytosine signature in circulating cell-free DNA as a potential diagnostic factor for early-stage colorectal cancer and precancerous adenoma.
    Xiao Z; Wu W; Wu C; Li M; Sun F; Zheng L; Liu G; Li X; Yun Z; Tang J; Yu Y; Luo S; Sun W; Feng X; Cheng Q; Tao X; Wu S; Tao J
    Mol Oncol; 2021 Jan; 15(1):138-150. PubMed ID: 33107199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients.
    Gao P; Lin S; Cai M; Zhu Y; Song Y; Sui Y; Lin J; Liu J; Lu X; Zhong Y; Cui Y; Zhou P
    J Cell Mol Med; 2019 May; 23(5):3530-3537. PubMed ID: 30912288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D
    J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 5-Hydroxymethylcytosine-Based Noninvasive Model for Early Detection of Colorectal Carcinomas and Advanced Adenomas: The METHOD-2 Study.
    Chang W; Zhang Z; Jia B; Ding K; Pan Z; Su G; Zhang W; Liu T; Zhong Y; He G; Ren L; Wei Y; Li D; Cui X; Yang J; Shi Y; Bissonnette M; He C; Zhang W; Fan J; Xu J
    Clin Cancer Res; 2024 Aug; 30(15):3337-3348. PubMed ID: 38814264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    West-Szymanski DC; Zhang Z; Cui XL; Kowitwanich K; Gao L; Deng Z; Dougherty U; Williams C; Merkle S; He C; Zhang W; Bissonnette M
    JCO Precis Oncol; 2024 Oct; 8():e2400277. PubMed ID: 39393034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
    Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
    Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.
    Tong X; Chen W; Ye L; Xiong Y; Xu Y; Luo Y; Xia X; Xu Z; Lin Y; Zhu X; Wang N; Xue X; Zhang H; Guo G
    Lupus Sci Med; 2024 Oct; 11(2):. PubMed ID: 39366755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease.
    Beadell AV; Zhang Z; Capuano AW; Bennett DA; He C; Zhang W; Arvanitakis Z
    J Alzheimers Dis; 2023; 93(3):1135-1151. PubMed ID: 37182870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
    Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
    BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of 5-hydroxymethylcytosines from circulating cell-free DNA in diffuse large B-cell lymphoma.
    Chiu BC; Zhang Z; You Q; Zeng C; Stepniak E; Bracci PM; Yu K; Venkataraman G; Smith SM; He C; Zhang W
    Blood Adv; 2019 Oct; 3(19):2790-2799. PubMed ID: 31570490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic and predictive biomarkers for coronary artery disease.
    Dong C; Chen J; Zheng J; Liang Y; Yu T; Liu Y; Gao F; Long J; Chen H; Zhu Q; He Z; Hu S; He C; Lin J; Tang Y; Zhu H
    Clin Epigenetics; 2020 Jan; 12(1):17. PubMed ID: 31964422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA.
    Guler GD; Ning Y; Ku CJ; Phillips T; McCarthy E; Ellison CK; Bergamaschi A; Collin F; Lloyd P; Scott A; Antoine M; Wang W; Chau K; Ashworth A; Quake SR; Levy S
    Nat Commun; 2020 Oct; 11(1):5270. PubMed ID: 33077732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of 5-hydroxymethylcytosines in circulating cell-free DNA reflect retinopathy in type 2 diabetes.
    Han L; Chen C; Lu X; Song Y; Zhang Z; Zeng C; Chiu R; Li L; Xu M; He C; Zhang W; Duan S
    Genomics; 2021 Jan; 113(1 Pt 1):79-87. PubMed ID: 33221518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma.
    Cai Z; Zhang J; He Y; Xia L; Dong X; Chen G; Zhou Y; Hu X; Zhong S; Wang Y; Chen H; Xie D; Liu X; Liu J
    ESMO Open; 2021 Feb; 6(1):100021. PubMed ID: 33508734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis.
    Shao J; Olsen RJ; Kasparian S; He C; Bernicker EH; Li Z
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
    Song CX; Yin S; Ma L; Wheeler A; Chen Y; Zhang Y; Liu B; Xiong J; Zhang W; Hu J; Zhou Z; Dong B; Tian Z; Jeffrey SS; Chua MS; So S; Li W; Wei Y; Diao J; Xie D; Quake SR
    Cell Res; 2017 Oct; 27(10):1231-1242. PubMed ID: 28820176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer.
    Hu H; Shu M; He L; Yu X; Liu X; Lu Y; Chen Y; Miao X; Chen X
    Br J Cancer; 2017 Feb; 116(5):658-668. PubMed ID: 28141796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-free DNA 5-hydroxymethylcytosine profiles of long non-coding RNA genes enable early detection and progression monitoring of human cancers.
    Zhou M; Hou P; Yan C; Chen L; Li K; Wang Y; Zhao J; Su J; Sun J
    Clin Epigenetics; 2021 Oct; 13(1):197. PubMed ID: 34689838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of circulating bacterial DNA in colorectal cancer and adenoma: A proof-of-concept study.
    Xiao Q; Lu W; Kong X; Shao YW; Hu Y; Wang A; Bao H; Cao R; Liu K; Wang X; Wu X; Zheng S; Yuan Y; Ding K
    Cancer Lett; 2021 Feb; 499():201-208. PubMed ID: 33249197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating small extracellular vesicle RNA profiling for the detection of T1a stage colorectal cancer and precancerous advanced adenoma.
    Min L; Bu F; Meng J; Liu X; Guo Q; Zhao L; Li Z; Li X; Zhu S; Zhang S
    Elife; 2024 Aug; 12():. PubMed ID: 39121006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.